Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 615

1.

Potent efficacy of MCL-1 inhibitor-based therapies in preclinical models of mantle cell lymphoma.

Dengler MA, Teh CE, Thijssen R, Gangoda L, Lan P, Herold MJ, Gray DH, Kelly GL, Roberts AW, Adams JM.

Oncogene. 2019 Nov 26. doi: 10.1038/s41388-019-1122-x. [Epub ahead of print]

PMID:
31772331
2.

HBO1(KAT7) does not have an essential role in cell proliferation, DNA replication or histone 4 acetylation in human cells.

Kueh AJ, Eccles S, Tang L, Garnham AL, May RE, Herold MJ, Smyth GK, Voss AK, Thomas T.

Mol Cell Biol. 2019 Nov 25. pii: MCB.00506-19. doi: 10.1128/MCB.00506-19. [Epub ahead of print]

PMID:
31767635
3.

Characterization of a novel human BFL-1-specific monoclonal antibody.

Gangoda L, Teh CE, Dengler MA, Best SA, Weeden CE, Tai L, Lee EF, Fairlie WD, Sutherland KD, Harrison LC, Gray DH, Strasser A, Herold MJ.

Cell Death Differ. 2019 Nov 12. doi: 10.1038/s41418-019-0454-y. [Epub ahead of print] No abstract available.

PMID:
31719651
4.

EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins.

Fitzsimmons L, Cartlidge R, Chang C, Sejic N, Galbraith LCA, Suraweera CD, Croom-Carter D, Dewson G, Tierney RJ, Bell AI, Shannon-Lowe C, Herold MJ, Rickinson AB, Colman PM, Huang DCS, Strasser A, Kvansakul M, Rowe M, Kelly GL.

Cell Death Differ. 2019 Oct 23. doi: 10.1038/s41418-019-0435-1. [Epub ahead of print]

PMID:
31645677
5.

Clinicopathologic comparison of Rowell syndrome, erythema multiforme, and subacute cutaneous lupus erythematosus.

Herold M, Nielson CB, Braswell D, Merkel K, Walker A, Auerbach J, Kapil J, Motaparthi K.

J Am Acad Dermatol. 2019 Dec;81(6):1435-1438. doi: 10.1016/j.jaad.2019.06.008. Epub 2019 Jun 13. No abstract available.

PMID:
31629618
6.

Intensification of dairy production can increase the GHG mitigation potential of the land use sector in East Africa.

Brandt P, Yesuf G, Herold M, Rufino MC.

Glob Chang Biol. 2019 Oct 16. doi: 10.1111/gcb.14870. [Epub ahead of print]

PMID:
31617288
7.

Response to 'Titre-specific positive predictive value of anti-nuclear antibody patterns' by Vulsteke et al.

Damoiseaux J, Andrade LEC, Fritzler MJ, Herold M, Infantino M, von Muhlen C.

Ann Rheum Dis. 2019 Oct 10. pii: annrheumdis-2019-216266. doi: 10.1136/annrheumdis-2019-216266. [Epub ahead of print] No abstract available.

PMID:
31601628
8.

miR17~92 restrains pro-apoptotic BIM to ensure survival of haematopoietic stem and progenitor cells.

Brinkmann K, Ng AP, de Graaf CA, Di Rago L, Hyland CD, Morelli E, Rautela J, Huntington ND, Strasser A, Alexander WS, Herold MJ.

Cell Death Differ. 2019 Oct 7. doi: 10.1038/s41418-019-0430-6. [Epub ahead of print]

PMID:
31591473
9.

Modeling breast cancer using CRISPR/Cas9-mediated engineering of human breast organoids.

Dekkers JF, Whittle JR, Vaillant F, Chen HR, Dawson C, Liu K, Geurts M, Herold MJ, Clevers H, Lindeman GJ, Visvader JE.

J Natl Cancer Inst. 2019 Oct 7. pii: djz196. doi: 10.1093/jnci/djz196. [Epub ahead of print]

PMID:
31589320
10.

Evaluation of Safety and Efficacy of Laser Hair Removal With the Long-Pulsed 755 nm Wavelength Laser: A Two-Center Study With 948 Patients.

Russe E, Purschke M, Herold M, Sakamoto FH, Wechselberger G, Russe-Wilflingseder K.

Lasers Surg Med. 2019 Oct 3. doi: 10.1002/lsm.23160. [Epub ahead of print]

PMID:
31579971
11.

[The Frieze of Life, or death, anxiety and love in the oeuvre of Edvard Munch].

Herold M, Kiss EC.

Psychiatr Hung. 2019;34(3):311-321. Hungarian.

PMID:
31570662
12.

Use of Topical and Systemic Retinoids in Solid Organ Transplant Recipients: Update and Review of the Current Literature.

Herold M, Good AJ, Nielson CB, Longo MI.

Dermatol Surg. 2019 Dec;45(12):1442-1449. doi: 10.1097/DSS.0000000000002072.

PMID:
31403546
13.

Drinking comfortably? Gender and affect among Danish pre-partiers.

Herold MD, Hunt G.

Int J Drug Policy. 2019 Aug 7. pii: S0955-3959(19)30195-1. doi: 10.1016/j.drugpo.2019.07.017. [Epub ahead of print]

14.

The Importance of Consistent Global Forest Aboveground Biomass Product Validation.

Duncanson L, Armston J, Disney M, Avitabile V, Barbier N, Calders K, Carter S, Chave J, Herold M, Crowther TW, Falkowski M, Kellner JR, Labrière N, Lucas R, MacBean N, McRoberts RE, Meyer V, Næsset E, Nickeson JE, Paul KI, Phillips OL, Réjou-Méchain M, Román M, Roxburgh S, Saatchi S, Schepaschenko D, Scipal K, Siqueira PR, Whitehurst A, Williams M.

Surv Geophys. 2019;40(4):979-999. doi: 10.1007/s10712-019-09538-8. Epub 2019 May 30. Review.

15.

Estimating aboveground net biomass change for tropical and subtropical forests: Refinement of IPCC default rates using forest plot data.

Requena Suarez D, Rozendaal DMA, De Sy V, Phillips OL, Alvarez-Dávila E, Anderson-Teixeira K, Araujo-Murakami A, Arroyo L, Baker TR, Bongers F, Brienen RJW, Carter S, Cook-Patton SC, Feldpausch TR, Griscom BW, Harris N, Hérault B, Honorio Coronado EN, Leavitt SM, Lewis SL, Marimon BS, Monteagudo Mendoza A, Kassi N'dja J, N'Guessan AE, Poorter L, Qie L, Rutishauser E, Sist P, Sonké B, Sullivan MJP, Vilanova E, Wang MMH, Martius C, Herold M.

Glob Chang Biol. 2019 Nov;25(11):3609-3624. doi: 10.1111/gcb.14767. Epub 2019 Aug 16. Review.

16.

Low number of intrafollicular T cells may predict favourable response to rituximab-based immuno-chemotherapy in advanced follicular lymphoma: a secondary analysis of a randomized clinical trial.

Budau L, Wilhelm C, Moll R, Jäkel J, Hirt C, Dölken G, Maschmeyer G, Neubauer E, Strauch K, Burchert A, Herold M, Neubauer A.

J Cancer Res Clin Oncol. 2019 Aug;145(8):2149-2156. doi: 10.1007/s00432-019-02961-9. Epub 2019 Jul 4.

17.

Single-Cell Transcriptomics Identifies the Adaptation of Scart1+ Vγ6+ T Cells to Skin Residency as Activated Effector Cells.

Tan L, Sandrock I, Odak I, Aizenbud Y, Wilharm A, Barros-Martins J, Tabib Y, Borchers A, Amado T, Gangoda L, Herold MJ, Schmidt-Supprian M, Kisielow J, Silva-Santos B, Koenecke C, Hovav AH, Krebs C, Prinz I, Ravens S.

Cell Rep. 2019 Jun 18;27(12):3657-3671.e4. doi: 10.1016/j.celrep.2019.05.064.

18.

An architectural understanding of natural sway frequencies in trees.

Jackson T, Shenkin A, Moore J, Bunce A, van Emmerik T, Kane B, Burcham D, James K, Selker J, Calders K, Origo N, Disney M, Burt A, Wilkes P, Raumonen P, Gonzalez de Tanago Menaca J, Lau A, Herold M, Goodman RC, Fourcaud T, Malhi Y.

J R Soc Interface. 2019 Jun 28;16(155):20190116. doi: 10.1098/rsif.2019.0116. Epub 2019 Jun 5.

PMID:
31164076
19.

ROCK1 but not LIMK1 or PAK2 is a key regulator of apoptotic membrane blebbing and cell disassembly.

Tixeira R, Phan TK, Caruso S, Shi B, Atkin-Smith GK, Nedeva C, Chow JDY, Puthalakath H, Hulett MD, Herold MJ, Poon IKH.

Cell Death Differ. 2019 May 1. doi: 10.1038/s41418-019-0342-5. [Epub ahead of print]

PMID:
31043701
20.

Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects.

Klotz L, Eschborn M, Lindner M, Liebmann M, Herold M, Janoschka C, Torres Garrido B, Schulte-Mecklenbeck A, Gross CC, Breuer J, Hundehege P, Posevitz V, Pignolet B, Nebel G, Glander S, Freise N, Austermann J, Wirth T, Campbell GR, Schneider-Hohendorf T, Eveslage M, Brassat D, Schwab N, Loser K, Roth J, Busch KB, Stoll M, Mahad DJ, Meuth SG, Turner T, Bar-Or A, Wiendl H.

Sci Transl Med. 2019 May 1;11(490). pii: eaao5563. doi: 10.1126/scitranslmed.aao5563.

PMID:
31043571
21.

BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival.

Lee EF, Harris TJ, Tran S, Evangelista M, Arulananda S, John T, Ramnac C, Hobbs C, Zhu H, Gunasingh G, Segal D, Behren A, Cebon J, Dobrovic A, Mariadason JM, Strasser A, Rohrbeck L, Haass NK, Herold MJ, Fairlie WD.

Cell Death Dis. 2019 Apr 24;10(5):342. doi: 10.1038/s41419-019-1568-3.

22.

Loss of p53 Causes Stochastic Aberrant X-Chromosome Inactivation and Female-Specific Neural Tube Defects.

Delbridge ARD, Kueh AJ, Ke F, Zamudio NM, El-Saafin F, Jansz N, Wang GY, Iminitoff M, Beck T, Haupt S, Hu Y, May RE, Whitehead L, Tai L, Chiang W, Herold MJ, Haupt Y, Smyth GK, Thomas T, Blewitt ME, Strasser A, Voss AK.

Cell Rep. 2019 Apr 9;27(2):442-454.e5. doi: 10.1016/j.celrep.2019.03.048.

23.

Deep neural networks outperform human expert's capacity in characterizing bioleaching bacterial biofilm composition.

Buetti-Dinh A, Galli V, Bellenberg S, Ilie O, Herold M, Christel S, Boretska M, Pivkin IV, Wilmes P, Sand W, Vera M, Dopson M.

Biotechnol Rep (Amst). 2019 Mar 7;22:e00321. doi: 10.1016/j.btre.2019.e00321. eCollection 2019 Jun.

24.

Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective.

Damoiseaux J, Andrade LEC, Carballo OG, Conrad K, Francescantonio PLC, Fritzler MJ, Garcia de la Torre I, Herold M, Klotz W, Cruvinel WM, Mimori T, von Muhlen C, Satoh M, Chan EK.

Ann Rheum Dis. 2019 Jul;78(7):879-889. doi: 10.1136/annrheumdis-2018-214436. Epub 2019 Mar 12.

25.

Memory effects of climate and vegetation affecting net ecosystem CO2 fluxes in global forests.

Besnard S, Carvalhais N, Arain MA, Black A, Brede B, Buchmann N, Chen J, Clevers JGPW, Dutrieux LP, Gans F, Herold M, Jung M, Kosugi Y, Knohl A, Law BE, Paul-Limoges E, Lohila A, Merbold L, Roupsard O, Valentini R, Wolf S, Zhang X, Reichstein M.

PLoS One. 2019 Feb 6;14(2):e0211510. doi: 10.1371/journal.pone.0211510. eCollection 2019. Erratum in: PLoS One. 2019 Feb 28;14(2):e0213467.

26.

Weak Iron Oxidation by Sulfobacillus thermosulfidooxidans Maintains a Favorable Redox Potential for Chalcopyrite Bioleaching.

Christel S, Herold M, Bellenberg S, Buetti-Dinh A, El Hajjami M, Pivkin IV, Sand W, Wilmes P, Poetsch A, Vera M, Dopson M.

Front Microbiol. 2018 Dec 12;9:3059. doi: 10.3389/fmicb.2018.03059. eCollection 2018.

27.

Transcription Factor PU.1 Promotes Conventional Dendritic Cell Identity and Function via Induction of Transcriptional Regulator DC-SCRIPT.

Chopin M, Lun AT, Zhan Y, Schreuder J, Coughlan H, D'Amico A, Mielke LA, Almeida FF, Kueh AJ, Dickins RA, Belz GT, Naik SH, Lew AM, Bouillet P, Herold MJ, Smyth GK, Corcoran LM, Nutt SL.

Immunity. 2019 Jan 15;50(1):77-90.e5. doi: 10.1016/j.immuni.2018.11.010. Epub 2019 Jan 2.

PMID:
30611612
28.

Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression.

Seymour JF, Marcus R, Davies A, Gallop-Evans E, Grigg A, Haynes A, Herold M, Illmer T, Nilsson-Ehle H, Sökler M, Dünzinger U, Nielsen T, Launonen A, Hiddemann W.

Haematologica. 2019 Jun;104(6):1202-1208. doi: 10.3324/haematol.2018.209015. Epub 2018 Dec 20.

29.

Foxp1 Is Indispensable for Ductal Morphogenesis and Controls the Exit of Mammary Stem Cells from Quiescence.

Fu NY, Pal B, Chen Y, Jackling FC, Milevskiy M, Vaillant F, Capaldo BD, Guo F, Liu KH, Rios AC, Lim N, Kueh AJ, Virshup DM, Herold MJ, Tucker HO, Smyth GK, Lindeman GJ, Visvader JE.

Dev Cell. 2018 Dec 3;47(5):629-644.e8. doi: 10.1016/j.devcel.2018.10.001. Epub 2018 Oct 25.

PMID:
30523786
30.

Isotretinoin and candida immunotherapy for recalcitrant warts in solid organ transplant recipients.

Herold M, Nielson C, Longo MI.

Dermatol Ther. 2019 Mar;32(2):e12803. doi: 10.1111/dth.12803. Epub 2019 Jan 6.

PMID:
30536495
31.

Birth mode is associated with earliest strain-conferred gut microbiome functions and immunostimulatory potential.

Wampach L, Heintz-Buschart A, Fritz JV, Ramiro-Garcia J, Habier J, Herold M, Narayanasamy S, Kaysen A, Hogan AH, Bindl L, Bottu J, Halder R, Sjöqvist C, May P, Andersson AF, de Beaufort C, Wilmes P.

Nat Commun. 2018 Nov 30;9(1):5091. doi: 10.1038/s41467-018-07631-x.

32.

VDAC2 enables BAX to mediate apoptosis and limit tumor development.

Chin HS, Li MX, Tan IKL, Ninnis RL, Reljic B, Scicluna K, Dagley LF, Sandow JJ, Kelly GL, Samson AL, Chappaz S, Khaw SL, Chang C, Morokoff A, Brinkmann K, Webb A, Hockings C, Hall CM, Kueh AJ, Ryan MT, Kluck RM, Bouillet P, Herold MJ, Gray DHD, Huang DCS, van Delft MF, Dewson G.

Nat Commun. 2018 Nov 26;9(1):4976. doi: 10.1038/s41467-018-07309-4.

33.

Added value of plasma metabolomics to describe maternal effects in rat maternal and prenatal toxicity studies.

Keller J, Mellert W, Sperber S, Kamp H, Jiang X, Fabian E, Herold M, Walk T, Strauss V, van Ravenzwaay B.

Toxicol Lett. 2019 Feb;301:42-52. doi: 10.1016/j.toxlet.2018.10.032. Epub 2018 Nov 9.

34.

A point mutation in the Ncr1 signal peptide impairs the development of innate lymphoid cell subsets.

Almeida FF, Tognarelli S, Marçais A, Kueh AJ, Friede ME, Liao Y, Willis SN, Luong K, Faure F, Mercier FE, Galluso J, Firth M, Narni-Mancinelli E, Rais B, Scadden DT, Spallotta F, Weil S, Giannattasio A, Kalensee F, Zöller T, Huntington ND, Schleicher U, Chiocchetti AG, Ugolini S, Herold MJ, Shi W, Koch J, Steinle A, Vivier E, Walzer T, Belz GT, Ullrich E.

Oncoimmunology. 2018 Aug 15;7(10):e1475875. doi: 10.1080/2162402X.2018.1475875. eCollection 2018.

35.

GM-CSF Quantity Has a Selective Effect on Granulocytic vs. Monocytic Myeloid Development and Function.

Sun L, Rautela J, Delconte RB, Souza-Fonseca-Guimaraes F, Carrington EM, Schenk RL, Herold MJ, Huntington ND, Lew AM, Xu Y, Zhan Y.

Front Immunol. 2018 Aug 28;9:1922. doi: 10.3389/fimmu.2018.01922. eCollection 2018.

36.

Characterisation of mice lacking the inflammatory caspases-1/11/12 reveals no contribution of caspase-12 to cell death and sepsis.

Salvamoser R, Brinkmann K, O'Reilly LA, Whitehead L, Strasser A, Herold MJ.

Cell Death Differ. 2019 Jun;26(6):1124-1137. doi: 10.1038/s41418-018-0188-2. Epub 2018 Aug 28.

PMID:
30154447
37.

Humanized Mcl-1 mice enable accurate preclinical evaluation of MCL-1 inhibitors destined for clinical use.

Brennan MS, Chang C, Tai L, Lessene G, Strasser A, Dewson G, Kelly GL, Herold MJ.

Blood. 2018 Oct 11;132(15):1573-1583. doi: 10.1182/blood-2018-06-859405. Epub 2018 Aug 23.

PMID:
30139826
38.

Rapamycin for refractory discoid lupus erythematosus.

Herold M, Richmond NA, Montuno MA, Wesson SK, Motaparthi K.

Dermatol Ther. 2018 Sep;31(5):e12631. doi: 10.1111/dth.12631. Epub 2018 Aug 14.

PMID:
30109759
39.

Impact of lincosamides antibiotics on the composition of the rat gut microbiota and the metabolite profile of plasma and feces.

Behr C, Ramírez-Hincapié S, Cameron HJ, Strauss V, Walk T, Herold M, Beekmann K, Rietjens IMCM, van Ravenzwaay B.

Toxicol Lett. 2018 Oct 15;296:139-151. doi: 10.1016/j.toxlet.2018.08.002. Epub 2018 Aug 10.

PMID:
30102961
40.

Automated Microscopic Analysis of Metal Sulfide Colonization by Acidophilic Microorganisms.

Bellenberg S, Buetti-Dinh A, Galli V, Ilie O, Herold M, Christel S, Boretska M, Pivkin IV, Wilmes P, Sand W, Vera M, Dopson M.

Appl Environ Microbiol. 2018 Oct 1;84(20). pii: e01835-18. doi: 10.1128/AEM.01835-18. Print 2018 Oct 15.

41.

TRIM17 and TRIM28 antagonistically regulate the ubiquitination and anti-apoptotic activity of BCL2A1.

Lionnard L, Duc P, Brennan MS, Kueh AJ, Pal M, Guardia F, Mojsa B, Damiano MA, Mora S, Lassot I, Ravichandran R, Cochet C, Aouacheria A, Potts PR, Herold MJ, Desagher S, Kucharczak J.

Cell Death Differ. 2019 May;26(5):902-917. doi: 10.1038/s41418-018-0169-5. Epub 2018 Jul 24.

PMID:
30042493
42.

Mining the Plasma Cell Transcriptome for Novel Cell Surface Proteins.

Trezise S, Karnowski A, Fedele PL, Mithraprabhu S, Liao Y, D'Costa K, Kueh AJ, Hardy MP, Owczarek CM, Herold MJ, Spencer A, Shi W, Willis SN, Nutt SL, Corcoran LM.

Int J Mol Sci. 2018 Jul 24;19(8). pii: E2161. doi: 10.3390/ijms19082161.

43.

Microbiome-related metabolite changes in gut tissue, cecum content and feces of rats treated with antibiotics.

Behr C, Sperber S, Jiang X, Strauss V, Kamp H, Walk T, Herold M, Beekmann K, Rietjens IMCM, van Ravenzwaay B.

Toxicol Appl Pharmacol. 2018 Sep 15;355:198-210. doi: 10.1016/j.taap.2018.06.028. Epub 2018 Jul 6.

PMID:
30008377
44.

MARCH1-mediated ubiquitination of MHC II impacts the MHC I antigen presentation pathway.

Wilson KR, Liu H, Healey G, Vuong V, Ishido S, Herold MJ, Villadangos JA, Mintern JD.

PLoS One. 2018 Jul 12;13(7):e0200540. doi: 10.1371/journal.pone.0200540. eCollection 2018.

45.

DNA repair processes are critical mediators of p53-dependent tumor suppression.

Janic A, Valente LJ, Wakefield MJ, Di Stefano L, Milla L, Wilcox S, Yang H, Tai L, Vandenberg CJ, Kueh AJ, Mizutani S, Brennan MS, Schenk RL, Lindqvist LM, Papenfuss AT, O'Connor L, Strasser A, Herold MJ.

Nat Med. 2018 Jul;24(7):947-953. doi: 10.1038/s41591-018-0043-5. Epub 2018 Jun 11.

PMID:
29892060
46.

Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety.

Hiddemann W, Barbui AM, Canales MA, Cannell PK, Collins GP, Dürig J, Forstpointner R, Herold M, Hertzberg M, Klanova M, Radford J, Seymour JF, Tobinai K, Trotman J, Burciu A, Fingerle-Rowson G, Wolbers M, Nielsen T, Marcus RE.

J Clin Oncol. 2018 Aug 10;36(23):2395-2404. doi: 10.1200/JCO.2017.76.8960. Epub 2018 Jun 1.

PMID:
29856692
47.

International consensus on antinuclear antibody patterns: definition of the AC-29 pattern associated with antibodies to DNA topoisomerase I.

Andrade LEC, Klotz W, Herold M, Conrad K, Rönnelid J, Fritzler MJ, von Mühlen CA, Satoh M, Damoiseaux J, de Melo Cruvinel W, Chan EKL; Executive Committee of ICAP.

Clin Chem Lab Med. 2018 Sep 25;56(10):1783-1788. doi: 10.1515/cclm-2018-0188. No abstract available.

48.

[The occurrence and impact on survival of type 2 diabetes mellitus and thrombocytosis in colorectal cancer, before and after the surgical resection of the primary tumor].

Herold Z, Ambrus V, Herold M, Herczeg G, Igaz P, Harsányi L, Somogyi A.

Orv Hetil. 2018 May;159(19):756-767. doi: 10.1556/650.2018.31038. Hungarian.

PMID:
29730943
49.

International Consensus on Antinuclear Antibody Patterns: defining negative results and reporting unidentified patterns.

Herold M, Klotz W, Andrade LEC, Conrad K, de Melo Cruvinel W, Damoiseaux J, Fritzler MJ, von Muhlen CA, Satoh M, Chan EKL.

Clin Chem Lab Med. 2018 Sep 25;56(10):1799-1802. doi: 10.1515/cclm-2018-0052. No abstract available.

PMID:
29634478
50.

Loss of NF-κB1 Causes Gastric Cancer with Aberrant Inflammation and Expression of Immune Checkpoint Regulators in a STAT-1-Dependent Manner.

O'Reilly LA, Putoczki TL, Mielke LA, Low JT, Lin A, Preaudet A, Herold MJ, Yaprianto K, Tai L, Kueh A, Pacini G, Ferrero RL, Gugasyan R, Hu Y, Christie M, Wilcox S, Grumont R, Griffin MDW, O'Connor L, Smyth GK, Ernst M, Waring P, Gerondakis S, Strasser A.

Immunity. 2018 Mar 20;48(3):570-583.e8. doi: 10.1016/j.immuni.2018.03.003.

Supplemental Content

Loading ...
Support Center